Peptide synthétique PHAP III humain
- Référence fabricant
- PEP-0142
- NACRES
- NA.26
170,91 €
HT
205,09 € TTC| Réf.Référence | Conditionnement | Prix HT | Quantité |
|---|---|---|---|
| C057096 | 1 flacon | 170,91 €205,09 € TTC |
Description
This peptide corresponds to amino acides near the carboxy terminus of humain PHAP III. PEP-0142 can be used as a blocking peptide avec polyclonal anticorps PA5-20023.
• Espèces : Humain
• Conservateur : Azoture de sodium
• Alias de gène : 2810018A15Rik; Acide nuclear phosphoprotein 32 (leucine rich); acidic (leucine-rich) nuclear phosphoprotein 32 family, member A; acidic (leucine-rich) nuclear phosphoprotein 32 family, member E; acidic leucine-rich nuclear phosphoprotein 32 family member A; Acidic leucine-rich nuclear phosphoprotein 32 family member E; Acidic leucine-rich nuclear phosphoprotein 32 family member E-like protéine; acidic nuclear phosphoprotein 32; acidic nuclear phosphoprotein 32 family member A; acidic nuclear phosphoprotein 32 family member E; acidic nuclear phosphoprotein 32 family, member A; acidic nuclear phosphoprotein pp32; AI047746; AI326868; Anp32; Anp32a; Anp32e; C15orf1; cerebellar leucine rich acidic nuclear protéine; cerebellar postnatal development protéine 1; Cpd1; hepatopoietin Cn; HPPCn; I1PP2A; inhibitor-1 of protéine phosphatase-2A; LANP; LANPL; LANP-L; LANP-like protéine; Leucine-rich acidic nuclear protéine; leucine-rich acidic nuclear protéine LANP; leucine-rich acidic nuclear protéine like; MAPM; Mapmodulin; mLANP-L; PHAP1; PHAPI; Potent heat-stable protéine phosphatase 2A inhibitor I1PP2A; pp32; Putative HLA-DR-associated protéine I; putative humain HLA classe II associated protéine I; RP4-790G17.1; vacidic (leucine-rich) nuclear phosphoprotein 32 family, member A; W91701; wu:fb22e03; wu:fc04c12; wu:fc19a08; wu:fc79f04; wu:fi39c10; zgc:65995; zgc:85827
• Formule : PBS avec 0,1 % de BSA et 0,02 % d’azoture de sodium, pH 7,2
Caractéristiques techniques
| Espèces | Humain |
|---|---|
| Conservateur | Azoture de sodium |
| Alias de gène | 2810018A15Rik ; Acid nuclear phosphoprotein 32 (leucine rich) ; acidic (leucine-rich) nuclear phosphoprotein 32 family, member A ; acidic (leucine-rich) nuclear phosphoprotein 32 family, member E ; acidic leucine-rich nuclear phosphoprotein 32 family member A ; Acidic leucine-rich nuclear phosphoprotein 32 family member E ; Acidic leucine-rich nuclear phosphoprotein 32 family member E-like protein ; acidic nuclear phosphoprotein 32 ; acidic nuclear phosphoprotein 32 family member A ; acidic nuclear phosphoprotein 32 family member E ; acidic nuclear phosphoprotein 32 family, member A ; acidic nuclear phosphoprotein pp32 ; AI047746 ; AI326868 ; Anp32 ; Anp32a ; Anp32e ; C15orf1 ; cerebellar leucine rich acidic nuclear protein ; cerebellar postnatal development protein 1 ; Cpd1 ; hepatopoietin Cn ; HPPCn ; I1PP2A ; inhibitor-1 of protein phosphatase-2A ; LANP ; LANPL ; LANP-L ; LANP-like protein ; Leucine-rich acidic nuclear protein ; leucine-rich acidic nuclear protein LANP ; leucine-rich acidic nuclear protein like ; MAPM ; Mapmodulin ; mLANP-L ; PHAP1 ; PHAPI ; Potent heat-stable protein phosphatase 2A inhibitor I1PP2A ; pp32 ; Putative HLA-DR-associated protein I ; putative human HLA class II associated protein I ; RP4-790G17.1 ; vacidic (leucine-rich) nuclear phosphoprotein 32 family, member A ; W91701 ; wu:fb22e03 ; wu:fc04c12 ; wu:fc19a08 ; wu:fc79f04 ; wu:fi39c10 ; zgc:65995 ; zgc:85827 |
| Formule | PBS avec 0,1 % de BSA et 0,02 % d’azoture de sodium, pH 7,2 |
Détails (4)
- Marque
- Invitrogen
- Référence fabricant
- PEP-0142
- Température de stockage
- -20°C
- Contenance
- 50 µg
Aucun document en ligne pour ce produit. Besoin d’une fiche technique ou d’une FDS ? Demandez-la-nous.